An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ
NCT05413057
·
clinicaltrials.gov ↗
RECRUITING
Status
20000
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension,Essential
Sponsor
Boryung Pharmaceutical Co., Ltd